Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations
Authors:
- Marissa Howard-McNattMHMarissa Howard-McNatt
- Rebecca W. SchrollRSRebecca W. Schroll
- Gail J. HurtGHGail J. Hurt
- Edward A. LevineELEdward A. Levine
- 30 September 2011
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 202 (3) , 298-302
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance ImagingJournal of Clinical Oncology, 2009
- Patient and Surgeon Characteristics Associated with Increased Use of Contralateral Prophylactic Mastectomy in Patients with Breast CancerAnnals of Surgical Oncology, 2009
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutationCancer, 2009
- Diagnostic Breast Magnetic Resonance Imaging and Contralateral Prophylactic MastectomyAnnals of Surgical Oncology, 2009
- Unraveling the Next ChapterThe Cancer Journal, 2009
- Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutationClinical Genetics, 2007
- Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network ProjectJournal of Clinical Oncology, 2005
- Prophylactic mastectomy for the prevention of breast cancer2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002